Key Metrics
CiteScore 

12.1
Impact Factor 

5 - 10
SJR 

Q1Dermatology

SNIP 

3.02
Recommended pre-submission checks
Powered by 

Topics Covered on American Journal of Clinical Dermatology
American Journal of Clinical Dermatology Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in American Journal of Clinical Dermatology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in American Journal of Clinical Dermatology
Defining the Potential for Disease Modification in Atopic Dermatitis.
- 29 Jun 2026
- American journal of clinical dermatology
Atopic Dermatitis: New Targets and Emerging Systemic Therapies.
- 27 Jun 2026
- American journal of clinical dermatology
Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions.
- 22 Jun 2026
- American journal of clinical dermatology
Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
- 18 Jun 2026
- American journal of clinical dermatology
What's New in Photoprotection?
- 8 Jun 2026
- American journal of clinical dermatology
Primary Cutaneous Cryptococcosis in Immunocompetent Patients: Recognition and Management.
- 4 Jun 2026
- American journal of clinical dermatology
Defining the Potential for Disease Modification in Atopic Dermatitis.
- 29 Jun 2026
- American journal of clinical dermatology
Atopic Dermatitis: New Targets and Emerging Systemic Therapies.
- 27 Jun 2026
- American journal of clinical dermatology
Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions.
- 22 Jun 2026
- American journal of clinical dermatology
Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
- 18 Jun 2026
- American journal of clinical dermatology
What's New in Photoprotection?
- 8 Jun 2026
- American journal of clinical dermatology
Primary Cutaneous Cryptococcosis in Immunocompetent Patients: Recognition and Management.
- 4 Jun 2026
- American journal of clinical dermatology